Access the full text.
Sign up today, get DeepDyve free for 14 days.
Il-Jin Kim, Ja-Lok Ku, H. Kang, Jin Park, Kyong-Ah Yoon, Y. Shin, Hye-Rin Park, Sang‐Geun Jang, Soo-Jeong Lim, S. Han, Y. Shin, Min Lee, Seung-Yong Jeong, H. Shin, Jongmog Lee, Woo-Ho Kim, Jae‐Gahb Park (2004)
Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patientsHuman Genetics, 115
H. Vasen, Mecklin Jp, P. Khan, H. Lynch (1991)
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 34
J. Herman, J. Graff, S. Myöhänen, B. Nelkin, S. Baylin (1996)
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences of the United States of America, 93 18
Kristina Robinson, T. Liu, J. Vandrovcova, Britta Halvarsson, M. Clendenning, T. Frebourg, N. Papadopoulos, K. Kinzler, B. Vogelstein, P. Peltomäki, R. Kolodner, M. Nilbert, A. Lindblom (2007)
Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics.Journal of the National Cancer Institute, 99 4
M. Agostini, M. Enzo, L. Morandi, C. Bedin, S. Pizzini, Silvia Mason, R. Bertorelle, E. Urso, C. Mescoli, M. Lise, S. Pucciarelli, D. Nitti (2010)
A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors.Cancer biomarkers : section A of Disease markers, 6 1
C. Boland, M. Koi, D. Chang, J. Carethers (2007)
The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch Syndrome: from bench to bedsideFamilial Cancer, 7
B. Wullen, A. Mühlhöfer, W. Zoller (2001)
[Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer].Zeitschrift fur Gastroenterologie, 39 11
Nada Al-Tassan, N. Chmiel, J. Maynard, N. Fleming, Alison Livingston, Geraint Williams, A. Hodges, D. Davies, S. David, J. Sampson, J. Cheadle (2002)
Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumorsNature Genetics, 30
C. Pastrello, E. Pin, F. Marroni, C. Bedin, M. Fornasarig, M. Tibiletti, C. Oliani, M. Leòn, E. Urso, L. Puppa, M. Agostini, A. Viel (2011)
Integrated analysis of unclassified variants in mismatch repair genesGenetics in Medicine, 13
P. Peltomäki (2004)
Lynch Syndrome GenesFamilial Cancer, 4
S. Halford, A. Rowan, L. Lipton, O. Sieber, K. Pack, H. Thomas, S. Hodgson, W. Bodmer, I. Tomlinson (2003)
Germline mutations but not somatic changes at the MYH locus contribute to the pathogenesis of unselected colorectal cancers.The American journal of pathology, 162 5
Marina Croitoru, S. Cleary, N. Nicola, M. Manno, T. Selander, M. Aronson, M. Redston, M. Cotterchio, J. Knight, R. Gryfe, S. Gallinger (2004)
Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk.Journal of the National Cancer Institute, 96 21
H. Hampel, W. Frankel, E. Martin, M. Arnold, K. Khanduja, P. Kuebler, H. Nakagawa, Kaisa Sotamaa, T. Prior, J. Westman, J. Panescu, D. Fix, Janet Lockman, I. Comeras, A. Chapelle (2005)
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).The New England journal of medicine, 352 18
C. Boland, S. Thibodeau, S. Hamilton, D. Sidransky, J. Eshleman, R. Burt, S. Meltzer, M. Rodriguez-Bigas, R. Fodde, G. Ranzani, S. Srivastava (1998)
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.Cancer research, 58 22
F. Balaguer, S. Castellví-Bel, A. Castells, M. Andreu, J. Muñoz, J. Gisbert, X. Llor, R. Jover, R. Cid, V. Gonzalo, X. Bessa, R. Xicola, Elisenda Pons, C. Alenda, A. Payá, J. Piqué (2007)
Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 5 3
R. Jover, A. Castells, X. Llor, M. Andreu (2006)
Predictive value of microsatellite instability for benefit from adjuvant fluorouracil chemotherapy in colorectal cancer.Gut, 55 12
A. Knudsen, M. Bisgaard, S. Bülow (2004)
Attenuated familial adenomatous polyposis (AFAP): a review of the literatureFamilial Cancer, 2
N. Lindor, K. Rabe, G. Petersen, R. Haile, G. Casey, J. Baron, S. Gallinger, B. Bapat, M. Aronson, J. Hopper, J. Jass, L. LeMarchand, J. Grove, J. Potter, P. Newcomb, J. Terdiman, P. Conrad, Gabriella Moslein, R. Goldberg, A. Ziogas, H. Anton-Culver, M. Andrade, K. Siegmund, S. Thibodeau, L. Boardman, D. Seminara (2005)
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.JAMA, 293 16
D. Evans, S. Walsh, J. Jeacock, C. Robinson, L. Hadfield, D. Davies, R. Kingston (1997)
Incidence of hereditary non‐polyposis colorectal cancer in a population‐based study of 1137 consecutive cases of colorectal cancerBritish Journal of Surgery, 84
M. Agostini, M. Tibiletti, E. Lucci-Cordisco, A. Chiaravalli, H. Morreau, D. Furlan, L. Boccuto, S. Pucciarelli, C. Capella, M. Boiocchi, A. Viel (2005)
Two PMS2 Mutations in a Turcot Syndrome Family with Small Bowel CancersThe American Journal of Gastroenterology, 100
J. Lefèvre (2013)
Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors
J. Schouten, C. Mcelgunn, Raymond Waaijer, D. Zwijnenburg, Filip Diepvens, G. Pals (2002)
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.Nucleic acids research, 30 12
JR Sampson, N Jones (2009)
MUTYH-associated polyposisBest Pract Res Clin Gastroenterol, 23
N. Katballe, M. Christensen, F. Wikman, T. Ørntoft, Søren Laurberg (2002)
Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patientsGut, 50
LA Aaltonen, R Salovaara, P Kristo (1998)
Incidence of hereditary colorectal cancer and the feasibility of molecular screening for the diseaseNEJM, 338
F Balaguer, S Castellví-Bel, A Castells (2007)
Gastrointestinal oncology group of the Spanish gastroenterological association. Identification of MUTYH mutation carriers in colorectal cancer: a multicenter, case–control, population-based studyClin Gastroenterol Hepatol, 5
N. Lindor, L. Burgart, O. Leontovich, R. Goldberg, J. Cunningham, D. Sargent, C. Walsh-Vockley, G. Petersen, M. Walsh, B. Leggett, Joanne Young, M. Barker, J. Jass, J. Hopper, S. Gallinger, B. Bapat, M. Redston, S. Thibodeau (2002)
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 4
V. Piñol, A. Castells, M. Andreu, S. Castellví-Bel, C. Alenda, X. Llor, R. Xicola, F. Rodríguez-Moranta, A. Payá, R. Jover, X. Bessa (2005)
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.JAMA, 293 16
L. Aaltonen, R. Salovaara, P. Kristo, F. Canzian, A. Hemminki, P. Peltomäki, R. Chadwick, H. Kääriäinen, M. Eskelinen, H. Järvinen, J. Mecklin, A. Chapelle, A. Percesepe, H. Ahtola, N. Härkönen, R. Julkunen, Eero Kangas, S. Ojala, J. Tulikoura, E. Valkamo (1998)
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.The New England journal of medicine, 338 21
David Peel, A. Ziogas, E. Fox, M. Gildea, Beth Laham, Enedina Clements, R. Kolodner, H. Anton-Culver (2001)
Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases.Journal of the National Cancer Institute, 92 18
K. Imai, Hiroyuki Yamamoto (2008)
Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.Carcinogenesis, 29 4
E. Domingo, P. Laiho, M. Ollikainen, M. Pinto, Liang Wang, A. French, J. Westra, T. Frebourg, E. Espín, M. Armengol, R. Hamelin, Hiroyuki Yamamoto, R. Hofstra, R. Seruca, A. Lindblom, P. Peltomäki, S. Thibodeau, L. Aaltonen, S. Schwartz (2004)
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testingJournal of Medical Genetics, 41
H. Vasen, P. Watson, J. Mecklin, H. Lynch (1999)
New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.Gastroenterology, 116 6
R. Nascimbeni, S. Pucciarelli, D. Lorenzo, E. Urso, C. Casella, M. Agostini, D. Nitti, B. Salerni (2010)
Rectum-Sparing Surgery May be Appropriate for Biallelic MutYH-Associated PolyposisDiseases of the Colon & Rectum, 53
R. Salovaara, A. Loukola, P. Kristo, H. Kääriäinen, H. Ahtola, M. Eskelinen, N. Härkönen, R. Julkunen, Eero Kangas, S. Ojala, J. Tulikoura, E. Valkamo, H. Järvinen, J. Mecklin, L. Aaltonen, A. Chapelle (2000)
Population-based molecular detection of hereditary nonpolyposis colorectal cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 11
H. Görgens, S. Krüger, E. Kuhlisch*, C. Pagenstecher, Ruth Höhl, H. Schackert, A. Müller (2006)
Microsatellite stable colorectal cancers in clinically suspected hereditary nonpolyposis colorectal cancer patients without vertical transmission of disease are unlikely to be caused by biallelic germline mutations in MYH.The Journal of molecular diagnostics : JMD, 8 2
J. Groden, A. Thliveris, W. Samowitz, M. Carlson, L. Gelbert, H. Albertsen, G. Joslyn, J. Stevens, L. Spirio, M. Robertson, L. Sargeant, K. Krapcho, E. Wolff, R. Burt, J. Hughes, J. Warrington, J. McPherson, J. Wasmuth, D. Paslier, H. Abderrahim, D. Cohen, M. Leppert, Raymond White (1991)
Identification and characterization of the familial adenomatous polyposis coli geneCell, 66
J. Carethers (2006)
Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.Gut, 55 12
H. Davies, G. Bignell, Charles Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, Mathew Garnett, W. Bottomley, Neil Davis, E. Dicks, Rebecca Ewing, Yvonne Floyd, K. Gray, S. Hall, R. Hawes, Jaime Hughes, Vivian Kosmidou, A. Menzies, Catherine Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, Rebecca Wilson, H. Jayatilake, B. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. Riggins, D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, Judy Ho, Suet Leung, S. Yuen, Barbara Weber, H. Seigler, T. Darrow, H. Paterson, R. Marais, Christopher Marshall, R. Wooster, Michael Stratton, P. Futreal (2002)
Mutations of the BRAF gene in human cancerNature, 417
A. Avezzù, M. Agostini, S. Pucciarelli, Mauro Lise, E. Urso, I. Mammi, I. Maretto, M. Enzo, C. Pastrello, M. Lise, D. Nitti, A. Viel (2008)
The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle.Cancer letters, 268 2
N. Lindor (1999)
Suspected Hereditary Nonpolyposis Colorectal Cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) Criteria and Results of Genetic DiagnosisDiseases of The Colon & Rectum, 42
H. Rajagopalan, A. Bardelli, C. Lengauer, K. Kinzler, B. Vogelstein, V. Velculescu (2002)
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair statusNature, 418
(2000)
Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1
V Piñol, A Castells, M Andreu (2005)
for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancerJAMA, 293
C. Ribic, D. Sargent, M. Moore, S. Thibodeau, A. French, R. Goldberg, S. Hamilton, P. Laurent-Puig, R. Gryfe, L. Shepherd, D. Tu, M. Redston, S. Gallinger (2003)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.The New England journal of medicine, 349 3
V. Gismondi, M. Meta, L. Bonelli, P. Radice, P. Sala, L. Bertario, A. Viel, M. Fornasarig, A. Arrigoni, M. Gentile, M. Leòn, Luca Anselmi, C. Mareni, P. Bruzzi, L. Varesco (2004)
Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomasInternational Journal of Cancer, 109
(2012)
Tumor Biol
L. Ruo, C. Cellini, Jorge La-Calle, Melissa Murray, H. Thaler, S. Quan, J. Guillem (2001)
Limitations of family cancer history assessment at initial surgical consultationDiseases of the Colon & Rectum, 44
A. Percesepe, F. Borghi, M. Menigatti, L. Losi, M. Foroni, C. Gregorio, G. Rossi, M. Pedroni, E. Sala, F. Vaccina, L. Roncucci, P. Benatti, A. Viel, M. Genuardi, G. Marra, P. Kristo, P. Peltomäki, M. Leòn (2001)
Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 19 19
G. Deng, I. Bell, S. Crawley, J. Gum, J. Terdiman, Brian Allen, B. Truta, M. Sleisenger, Y. Kim (2004)
BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal CancerClinical Cancer Research, 10
M. Menigatti, C. Gregorio, F. Borghi, E. Sala, A. Scarselli, M. Pedroni, M. Foroni, P. Benatti, L. Roncucci, M. Leòn, A. Percesepe (2001)
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancerGenes, 31
The reported incidence of hereditary colorectal cancers (CRCs) is widely variable. The principal aim of the study was to prospectively evaluate the incidence of familial CRCs in a region of northern Italy using a standardized method. Consecutive CRC patients were prospectively enrolled from October 2002 to December 2003. Patients underwent a structured family history, the microsatellite instability (MSI) test and a screen for MUTYH mutations. Following family history patients were classified as belonging to high, moderate and mild risk families. Immunohistochemistry for MLH1, MSH2, MSH6 and PMS2 proteins and investigation for MLH1/MSH2 mutations, for MLH1 promoter methylation and for the V600E hotspot BRAF mutation were performed in high MSI (MSI-H) cases. Of the 430 patients enrolled, 17 (4%) were high risk [4 hereditary non-polyposis colorectal cancer (HNPCC), 12 suspected HNPCC and 1 MUTYH-associated adenomatous polyposis coli (MAP)], 53 moderate risk and 360 mild risk cases. The MSI test was performed on 393 tumours, and 46 (12%) of them showed MSI-H. In these patients, one MLH1 pathogenetic mutations and two MSH2 pathogenetic mutations were found. Thirty-two (70%) MSI-H cases demonstrated MLH1 methylation and/or BRAF mutation: None of them showed MLH1/MSH2 mutation. Two biallelic germline MUTYH mutations were found, one with clinical features of MAP. A strong family history of CRC was present in 4% of the enrolled cases; incidence of MLH1/MSH2 or MUTHY mutations was 1.3% and of MSI-H phenotype was 12%. MLH1 methylation and BRAF mutation can exclude 70% of MSI-H cases from gene sequencing.
Tumor Biology – Springer Journals
Published: Jan 26, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.